A. Chilles

Immune gene expression in head and neck squamous cell carcinoma patients.

O. Mariani, J. Klijanienko, S. Vacher, 2019, European journal of cancer.

Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results.

A. Fourquet, E. Costa, F. Campana, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Normofractionated breast irradiation in breast cancer. Indications and benefits].

A. Fourquet, F. Campana, Y. Kirova, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022

Michael R Hamblin, M. Hamblin, J. Bjordal, 2022, Frontiers in Oncology.

Curative high‐dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure

I. Buvat, A. Beddok, O. Choussy, 2022, Head & neck.

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma

J. Klijanienko, S. Vacher, I. Bièche, 2020, Cancer biology & medicine.

Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx.

S. Salas, V. Moreno, X. Mirabel, 2021, European journal of cancer.

Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.

I. Buvat, A. Beddok, O. Choussy, 2023, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[Best practice guide for radiation therapy of non-small cell bronchial cancers].

M. Ayadi, L. Claude, P. Fournel, 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.